Chengde Wu

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
1
2017
Encysive Pharmaceuticals, Inc.
2
2
1
2
5
4
5
11
1
8
1
2
1993
1994
1995
1996
1997
1999
2000
2001
2003
2004
2005
2007
TEXAS BIOTECHNOLOGY, INC.
1
2000
CISEN PHARMACEUTICAL CO., LTD.
2
2015
PFIZER INC.
1
2007
MEDSHINE DISCOVERY INC.
2
2014
NOVARTIS AG
1
2014
GLAXOSMITHKLINE LLC
2
2010
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
2
2015
ENYSIVE PHARMACEUTICALS INC.
1
1996
HUMANWELL HEALTHCARE (GROUP) CO., LTD.
1
2017
ENCYSIVE PHARMACEUTIVCALS, INC.
1
1999
QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD.
2
2014
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
4
2
2014
2015

Inventor Addresses

AddressDuration
HOUSTON, TX, USSep 13, 01 - Sep 13, 01
Houston, TXJul 21, 98 - Jan 27, 04
Houston, TX, USNov 08, 01 - Jul 11, 02
Jiangsu, CNSep 03, 20 - Jan 09, 24
Pearland, TXApr 01, 03 - Jan 22, 08
Pearland, TX, USNov 01, 01 - Oct 12, 10
SHANGHAI, CNOct 22, 20 - Oct 22, 20
San Diego, CANov 07, 95 - Apr 23, 02
Shanghai, CNMar 29, 12 - Mar 25, 25
Wuhan, CNNov 02, 17 - May 26, 20

Technology Profile

Technology Matters
A61D: VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS 1
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 48
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 25

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
122583672025Glucoside derivative that acts as SGLT1 inhibitor and application thereof0
2024/0390,3882024TRICYCLIC COMPOUNDS AND USE THEREOF0
2024/0368,1782024IMIDAZOCYCLIC COMPOUND AND APPLICATION THEREOF0
2024/0309,0182024THIAZOLE-LACTAM-SPIROHETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF0
2024/0300,9752024DIMETHYL-SUBSTITUTED THIAZOLOLACTAM COMPOUND AND USE THEREOF0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.